XOLAIR
Solution for injection in pre-filled syringe, 150mg
RxActive license
Active substance (INN)
omalizumab
Pharmaceutical form
Pharmaceutical formSolution for injection in pre-filled syringe
Strength150mg
PackagingUkupno 1 napunjeni injekcioni špric sa 1ml rastvora za injekciju u kartonskoj kutiji
ManufacturerNovartis Pharma Stein AG, Switzerland
Therapeutic groupRespiratory system (R03DX05)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateDecember 24, 2024
Analogs in Montenegro
3Other medicines with the same active substance
Source: CInMED register